Corbus Pharmaceuticals Holdings, Inc..
CRBP.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Corbus Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory, fibrotic, and metabolic diseases. The company's lead product candidate is lenabasum, a synthetic, selective cannabinoid receptor type 2 (...Show More
Better Health for All
0
No evidence available to assess Corbus Pharmaceuticals Holdings, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Corbus Pharmaceuticals Holdings, Inc. (CRBP.US) is a biopharmaceutical company focused on drug development, clinical trials, and regulatory approvals.
1
Its core business does not involve lending, insuring, moving, or storing money, nor does it offer consumer financial products or services.
2
Therefore, all Key Performance Indicators related to 'Fair Money & Economic Opportunity' are not applicable to CRBP.US, as its operations fall outside the scope of financial services.
Fair Pay & Worker Respect
0
No evidence available to assess Corbus Pharmaceuticals Holdings, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Corbus Pharmaceuticals Holdings, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete evidence was found in the provided articles to assess Corbus Pharmaceuticals Holdings, Inc. against any of the KPIs for the 'Honest & Fair Business' value. The articles primarily contain financial reporting, executive and director compensation details, and general corporate governance document listings (like a Code of Business Conduct and Ethics), but lack quantitative data on regulatory fines, transparency index scores, whistleblower policy strength, financial restatements, audit coverage percentages, ESG controversy scores, complaint resolution times, the percentage of conflict-free board members, anti-corruption policy details, or third-party verification of ethical claims.
1
While some articles mention that 'certain directors are independent,' this is not a quantifiable percentage and therefore cannot be scored against the 'board_conflict_free_pct' KPI.
2
Kind to Animals
0
The provided article discusses initiatives and investments by Charles River Laboratories and Sanofi, including their collaboration on Virtual Control Groups and Charles River's investment in alternative testing methods.
1
However, it does not contain any specific evidence or data points related to Corbus Pharmaceuticals Holdings, Inc. (CRBP.US) for any of the 'Kind to Animals' KPIs.
No War, No Weapons
0
No evidence available to assess Corbus Pharmaceuticals Holdings, Inc. on No War, No Weapons.
Planet-Friendly Business
0
No evidence available to assess Corbus Pharmaceuticals Holdings, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess Corbus Pharmaceuticals Holdings, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
10
Corbus Pharmaceuticals Holdings, Inc. complies with and is certified to the EU-U.S. Data Privacy Framework, its UK Extension, and the Swiss-U.S. Data Privacy Framework Principles.
1
The company annually provides employees with a data protection, cybersecurity, and incident response and prevention training and compliance program.
2
It implements reasonable and appropriate security measures to protect personal information from loss, misuse, and unauthorized access.
3
Users have the right to access, correct, amend, or delete their personal information, restrict processing, and receive a copy of their data.
4
The company limits personal data collection to the minimum necessary for stated purposes and receives only Key-Coded Data from clinical trials, where identifying information is removed by clinical trial personnel.
5
The company also reviews its third-party vendors for risk management procedures and has its audit committee provide oversight over cybersecurity risk.
6
Employees are required to notify the company urgently, if practicable within one hour, upon discovering a data breach.
7
Employees are also required to lock computer terminals when unattended and ensure wireless networks are secure.
8
The company outsources its IT environment to third-party providers.
9
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles regarding Corbus Pharmaceuticals Holdings, Inc.'s performance on waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero-waste certifications, waste disposal violations, material efficiency, packaging-to-product ratios, waste reduction targets, supplier waste requirements, or customer waste education.
1
The articles discuss general sustainability challenges, regulatory frameworks, or clinical trial information, but do not provide company-specific metrics or actions related to zero waste and sustainable products.